Stockreport

AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells

AgeX Therapeutics, Inc.  (AGE) 
PDF First research collaboration for immunotolerance UniverCyteTM technology platform, marking launch of new business development and collaboration strategySecures milestone [Read more]